会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Smart Microscope System for Radiation Biodosimetry
    • US20210124904A1
    • 2021-04-29
    • US17137317
    • 2020-12-29
    • Peter Keith RoganYanxin LiJin Liu
    • Peter Keith RoganYanxin LiJin Liu
    • G06K9/00G06T5/50G01T1/02G06T5/00
    • Automation of microscopic pathological diagnosis relies on digital image quality, which, in turn, affects the rates of false positive and negative cellular objects designated as abnormalities. Cytogenetic biodosimetry is a genotoxic assay that detects dicentric chromosomes (DCs) arising from exposure to ionizing radiation. The frequency of DCs is related to radiation dose received, so the inferred radiation dose depends on the accuracy of DC detection. To improve this accuracy, image segmentation methods are used to rank high quality cytogenetic images and eliminate suboptimal metaphase cell data in a sample based on novel quality measures. When sufficient numbers of high quality images are found, the microscope system is directed to terminate metaphase image collection for a sample. The International Atomic Energy Agency recommends at least 500 images be used to estimate radiation dose, however often many more images are collected in order to select the metaphase cells with good morphology for analysis. Improvements in DC recognition increase the accuracy of dose estimates, by reducing false positive (FP) DC detection. A set of chromosome morphology segmentation methods selectively filtered out false DCs, arising primarily from extended prometaphase chromosomes, sister chromatid separation and chromosome fragmentation. This reduced FPs by 55% and was highly specific to the abnormal structures (≥97.7%). Additional procedures were then developed to fully automate image review, resulting in 6 image-level filters that, when combined, selectively remove images with consistently unparsable or incorrectly segmented chromosome morphologies. Overall, these filters can eliminate half of the FPs detected by manual image review. Optimal image selection and FP DCs are minimized by combining multiple feature based segmentation filters and a novel image sorting procedure based on the known distribution of chromosome lengths. Consequently, the average dose estimation error was reduced from 0.4 Gy to
    • 4. 发明申请
    • Process and Apparatus for Purifying Water
    • 净化水的工艺和设备
    • US20130319947A1
    • 2013-12-05
    • US13805571
    • 2011-06-24
    • William Peter Keith Kennedy
    • William Peter Keith Kennedy
    • C02F1/24
    • C02F1/24B01D17/0205C02F1/004C02F1/32C02F1/78C02F2103/002C02F2209/38C02F2209/40
    • The invention relates to a process and apparatus that treats waste water, in particular waste water containing surfactants and including grey water, for local reuse. According to the invention, the process comprises a) collecting waste water in a reservoir; b) injecting gas into waste water from the reservoir to form bubbles in the waste water; c) separating the bubbles, and any entrained contaminants, from the waste water; d) drying the separated bubbles and returning any water recovered from the dried bubbles to the waste water undergoing treatment; e) optionally repeating steps b) to d) to achieve the desired purification of the waste water; and f) collecting the purified waste water. The invention provides a robust process and a mechanically simple apparatus that does not require regular replacement of chemicals or filters, yet is capable of treating waste water locally, and in particular grey water for household reuse
    • 本发明涉及处理废水,特别是含有表面活性剂的废水和包括灰水在内的方法和设备,用于本地再利用。 根据本发明,该方法包括:a)在储存器中收集废水; b)将气体从储层注入废水中,在废水中形成气泡; c)从废水中分离气泡和任何夹带的污染物; d)干燥分离的气泡并将从干燥气泡回收的任何水返回到经过处理的废水; e)任选地重复步骤b)至d)以实现废水的所需净化; 和f)收集纯化废水。 本发明提供了一种坚固的方法和机械简单的装置,其不需要定期更换化学品或过滤器,而是能够局部处理废水,特别是用于家庭再利用的灰水
    • 5. 发明申请
    • STIMULUS REGIMENS FOR CARDIOVASCULAR REFLEX CONTROL
    • 用于心脏反射控制的刺激方案
    • US20120290037A1
    • 2012-11-15
    • US13534237
    • 2012-06-27
    • Robert S. KievalDavid J. SerdarBruce J. PerssonPeter Keith
    • Robert S. KievalDavid J. SerdarBruce J. PerssonPeter Keith
    • A61N1/36
    • A61N1/36114A61N1/0551A61N1/0558A61N1/36007A61N1/36117A61N1/3627A61N1/36514
    • Baroreflex activation is achieved by providing suitable control signals to a baroreflex activation device. A method comprises establishing a therapy interval within the therapy interval, establishing a plurality of dose intervals, and generating an electrical output signal. The electrical output signal has a time dependence such that the average electrical power applied to the baroreflex activation device differs between first and second portions of at least some dose intervals. Another method comprises establishing a series of therapy interval portions, during at least some therapy intervals, establishing a plurality of burst intervals, and generating an electrical output signal. The electrical output signal has a time dependence such that the average electrical power applied to the baroreflex activation device differs between first and second portions of the therapy intervals and also differs between first and second portions of at least some burst intervals.
    • 通过向压力反射激活装置提供合适的控制信号来实现巴罗反射激活。 一种方法包括在治疗间隔内建立治疗间隔,建立多个剂量间隔,以及产生电输出信号。 电输出信号具有时间依赖性,使得施加到压力反射激活装置的平均电功率在至少一些剂量间隔的第一和第二部分之间不同。 另一种方法包括在至少一些治疗间隔期间建立一系列治疗间隔部分,建立多个突发间隔,并产生电输出信号。 电输出信号具有时间依赖性,使得施加到压力反射激活装置的平均电功率在治疗间隔的第一和第二部分之间不同,并且在至少一些突发间隔的第一和第二部分之间也不同。
    • 9. 发明授权
    • Apparatus and method for performing an intravascular procedure and
exchanging an intravascular device
    • 用于进行血管内手术和交换血管内装置的装置和方法
    • US5645533A
    • 1997-07-08
    • US379091
    • 1995-01-26
    • David BlaeserJanita BurmeisterPeter KeithThomas Ressemann
    • David BlaeserJanita BurmeisterPeter KeithThomas Ressemann
    • A61M25/00A61M29/02
    • A61M25/104A61M2025/0004A61M2025/0047A61M2025/0079A61M2025/0098A61M2025/0175A61M2025/0183A61M2025/1063A61M2025/1079A61M2025/1093A61M25/0067A61M25/0069A61M25/0075
    • A method and apparatus are provided for performing a balloon angioplasty procedure and for exchanging a guide wire and an intravascular catheter during the procedure. An intravascular balloon catheter includes an elongated shaft having a proximal portion adapted to extend outside the body of a patient during use, a distal portion adapted for connection to a dilation balloon and adapted for positioning intravascularly during use, and an inflation lumen extending therethrough in fluid flow communication with the balloon. In one aspect of the invention, an elongated guide lumen is connected to the catheter such that the guide lumen and catheter are movable relative to each other during use. A proximal portion of the guide lumen is adapted to extend outside the body of a patient during use, and a distal portion of the guide lumen is adapted to extend distally of the balloon during use. In another aspect of the invention, one or both of a guide wire and an intravascular device can be withdrawn from the guide lumen while the guide lumen remains substantially stationary. In yet another aspect of the invention, proximal and distal seal members are adapted to provide a substantially sealing fit around an intravascular device to inhibit the egress of fluid from the balloon.
    • 提供了一种用于执行球囊血管成形术程序并在手术期间更换导丝和血管内导管的方法和装置。 血管内气囊导管包括细长轴,其具有适于在使用期间延伸到患者身体外部的近端部分,适于连接到扩张气囊的远端部分,并且适于在使用期间血管内定位,以及在流体中延伸穿过的充气腔 与气球的流动通信。 在本发明的一个方面,细长的引导腔连接到导管,使得引导腔和导管在使用期间可相对于彼此移动。 引导腔的近端部分适于在使用期间延伸到患者身体的外部,并且引导腔的远侧部分适于在使用期间向远端延伸。 在本发明的另一方面,引导管和血管内装置中的一个或两个可以在引导腔保持基本上静止的同时从引导腔中取出。 在本发明的另一方面,近端和远端密封构件适于提供围绕血管内装置的基本密封配合,以抑制流体从气囊的流出。